Navigation Links
A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction
Date:3/8/2013

tic variant of this enzyme.

"Tecarfarin was specifically designed not to be metabolized by any CYP enzymes, which means it may require less monitoring than warfarin. Some monitoring, according to experts, may still be needed to ensure patient compliance. Data from EMBRACE-AC trial showed that tecarfarin is a more effective OAC than warfarin in patients with a CYP2C9 genetic variant taking at least one CYP2C9 inhibitor despite close monitoring," said Dr Peter Milner , Executive Chairman of Armetheon and partner at AshHill Pharmaceutical Investments.  He added, "for approval of tecarfarin, we anticipate only one more pivotal clinical trial will be required which could be a 'real world', open label study involving about 2500 pre-defined patients."

Recent research indicates that patients with chronic renal dysfunction or failure have reduced or variable activity of CYP enzymes such as CYP2C9 and CYP3A4 as well as the transporter permeability glycoprotein (P-gp). This may explain warfarin's suboptimal performance in this patient population. Currently marketed novel non-monitored OACs (in particular, Factor Xa inhibitors) are eliminated via the kidney and most of them are metabolized via CYP3A4 enzymes in addition to interacting with the P-gp. This may explain the significant variability in anticoagulation response to the novel non-monitored OACs in patients with chronic renal dysfunction or failure.

"Genetic and other sources of variability in the drug metabolizing enzymes CYP3A4 and CYP2C9 or transport related proteins such a P-gp could lead to unpredictable variability in plasma levels of drugs that are metabolized/eliminated through these pathways, particularly if they are used with concomitant medications that may be inhibitors of these metabolic/elimination pathways," said Professor Leslie Z. Benet , former Chairman and Professor of Biopharmaceutical Sciences at University of
'/>"/>

SOURCE Armetheon, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
4. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
5. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
8. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
9. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
10. OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
11. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  The annual customer satisfaction survey of over 5,700 ... #1 across all specialties. Every year, Florida ... poll of EHR users and publishes an internationally recognized ... Praxis EMR topped 348 other systems, with the ... used by Black Book. In addition to earning the ...
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... , May 29, 2015 Amgen (NASDAQ: ... two pivotal Phase 3, global, randomized, placebo-controlled trials ... treatment of secondary hyperparathyroidism (SHPT) in patients with ... met the primary endpoint, demonstrating that a greater ... achieved a greater than 30 percent reduction in ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc. – Florida, filed an Abbreviated New ... Drug Administration (FDA) seeking approval to market Dutasteride ... a generic version of GlaxoSmithKline,s AVODART(R), which is ...
... 20, 2011 The Consumer Healthcare Products Association ... Texas Governor Rick Perry signing into law legislation ... citizens to access common cold and allergy medicines ... the legal limit: "We applaud the ...
Cached Medicine Technology:Watson Confirms AVODART(R) Patent Challenge 2
(Date:5/29/2015)... RIDGELAND, Miss. (PRWEB) May 29, 2015 ... recently announced the graduates of its Advanced Training ... trains students, who fill roles in their health ... both the theory and methodology of continuous quality ... is a sister-program to Dr. Brent James’ internationally ...
(Date:5/29/2015)... York, New York (PRWEB) May 29, 2015 ... distributor of patented products, announces that it has signed ... Room, a technology patent that aims to let people ... industry experts in real time. , "This is an ... Chat Room " said Scott J. Cooper, CEO and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Inspire Nexus, ... created a solution to the question many life coaches ... gain the experience and hours necessary to become a ... pondered this question, but not for long. Inspire Nexus, ... to hire Coaches directly. Coaches who have experience coaching ...
(Date:5/29/2015)... has joined forces with Raw Elements Physical Eco Protection ... sun protection. The print component of “Skin Health” is ... 250,000 copies and an estimated readership of 750,000 readers. ... social media strategy, and across a network of top ... version of the campaign, click here . ...
(Date:5/29/2015)... 29, 2015 The campaign focuses on ... a number of specific concerns within, including the importance ... mental health in the workplace. We are encouraged to ... campaign also brings special focus to people living with ... up and seek help from healthcare professionals and their ...
Breaking Medicine News(10 mins):Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2
... early tooth decay, study finds , , FRIDAY, July 4 (HealthDay ... vitamin D during pregnancy may be at increased risk for ... study finds. , Researchers at the University of Manitoba analyzed ... trimester of pregnancy and found only 21 (10.5 percent) of ...
... Canada Low maternal vitamin D levels during ... defects, which are a risk factor for early-childhood ... of the,International Association for Dental Research, investigators from ... results of a study they conducted to determine ...
... (BUSM) and Boston Medical Center (BMC) found that patients ... of any type did not experience serious harm. However, ... obstetrics/gynecology setting received the most benefit. The findings, which ... , also conclude that disclosures made in an emergency ...
... Grubb & Ellis Healthcare,REIT, Inc. today announced it ... the addition of two skilled nursing facilities in,California. The ... four in Texas, the acquisition of which closed in ... El Monte and 1955 Lomita Blvd., in,Lomita, each of ...
... July 3 The Minnesota Nurses,Association (MNA) announced ... for U.S. House of Representatives, Congressional District 6., ... he shares a guiding principle,important to Minnesota nurses: ... ability to obtain healthcare," said MNA Political Committee,Chair, ...
... Hachinski has been named to the Order of Canada, ... the field of neurology. , Hachinski is a "Distinguished ... the Department of Clinical Neurological Sciences at the Schulich ... founding and current chairman of the International Society for ...
Cached Medicine News:Health News:Disclosing violence to primary care or obestetrics/gynecology physicians most beneficial 2Health News:Grubb & Ellis Healthcare REIT Acquires Senior Care Portfolio 1 in Calif. 2Health News:Grubb & Ellis Healthcare REIT Acquires Senior Care Portfolio 1 in Calif. 3Health News:Minnesota Nurses Association Endorses Elwyn Tinklenberg for Congress 2Health News:Pioneering stroke researcher awarded Canada's highest honor 2
Sighting and visualization system of the digital operating suite. The platform that links navigation, and intra-operative imaging to form the ultimate surgical workstation....
... OME-8000 represents the finest integration ... expertise in optics, digital imaging, ... a surgical microscope. The surgical ... gives the surgeon an unprecedented ...
The Leica MS1 F/MC1 F is designed to mount on the ceiling with a high degree of mobility. Its unique and patented suspension concept assures a superior stability and a perfect and steady microscope i...
Galilean Loupes...
Medicine Products: